Opinion: Renewed FDA funding will help bring new drugs to market
bizjournals.com
news
2022-10-21 17:00:00

Washington's biopharmaceutical sector, like our tech industry, is another national leader in cutting-edge technologies and innovations. Together, we strive to discover, develop and deliver new medicines and treatments.

Back in 2006, when I founded Advanced Cellular Dynamics (ACD), our focus was narrow, examining cell-based kinase assays. Since then, ACD has evolved to a robust provision of contract research services and our collective expertise spans numerous disciplines.

ACD's story is not dissimilar to those of our many counterparts.
